Nyxoah SA (EBR:NYXH)
Belgium
· Delayed Price · Currency is EUR 2.585
-0.015 (-0.58%)
Apr 28, 2026, 4:00 PM EDT
Nyxoah Revenue
In the year 2025, Nyxoah had annual revenue of 10.02M EUR with 121.63% growth. Nyxoah had revenue of 5.64M in the quarter ending December 31, 2025, with 346.87% growth.
Revenue
10.02M
Revenue Growth
+121.63%
P/S Ratio
11.26
Revenue / Employee
54.46K
Employees
184
Market Cap
112.87M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 3.61B |
| Financière de Tubize | 13.26K |
| Fagron NV | 952.17M |
| Ion Beam Applications | 620.20M |
| Onward Medical | 5.41M |
| Hyloris Pharmaceuticals | 8.83M |
| Sequana Medical NV | 105.50K |
Nyxoah News
- 15 hours ago - Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewsWire
- 5 weeks ago - Publication relating to transparency notifications - GlobeNewsWire
- 5 weeks ago - Nyxoah Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 6 weeks ago - Nyxoah Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Transcripts
- 6 weeks ago - Publication relating to transparency notification - GlobeNewsWire
- 6 weeks ago - Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 7 weeks ago - Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 - GlobeNewsWire